IE
TMCI icon

Israel Englander’s Treace Medical Concepts TMCI Stock Holding History

Israel Englander’s Portfolio TMCI Stock Details TMCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.94M Sell
738,628
-409,487
-36% -$1.13M ﹤0.01% 3498
2026
Q1 		$1.54M Sell
1,148,115
-354,796
-24% -$707K ﹤0.01% 4090
2025
Q4 		$3.68M Sell
1,502,911
-207,229
-12% -$900K ﹤0.01% 3345
2025
Q3 		$11.5M Buy
1,710,140
+192,929
+13% +$1.26M ﹤0.01% 2250
2025
Q2 		$8.92M Buy
1,517,211
+1,072,324
+241% +$6.99M ﹤0.01% 2381
2025
Q1 		$3.73M Buy
444,887
+116,114
+35% +$1.04M ﹤0.01% 3155
2024
Q4 		$2.45M Sell
328,773
-225,719
-41% -$1.51M ﹤0.01% 3467
2024
Q3 		$3.22M Sell
554,492
-131,520
-19% -$845K ﹤0.01% 3236
2024
Q2 		$4.56M Sell
686,012
-1,355,926
-66% -$11M ﹤0.01% 2810
2024
Q1 		$26.6M Buy
2,041,938
+1,359,999
+199% +$18.1M 0.01% 1299
2023
Q4 		$8.69M Buy
+681,939
New +$6.89M ﹤0.01% 2313
2023
Q3 		– Sell
-122,173
Closed -$3.13M – 6566
2023
Q2 		$3.13M Sell
122,173
-190,578
-61% -$4.92M ﹤0.01% 3101
2023
Q1 		$7.88M Buy
312,751
+264,490
+548% +$6.21M ﹤0.01% 2190
2022
Q4 		$1.11M Buy
+48,261
New +$1.11M ﹤0.01% 4062
2022
Q3 		– Sell
-306,376
Closed -$4.39M – 7497
2022
Q2 		$4.39M Sell
306,376
-315,917
-51% -$5.32M ﹤0.01% 2939
2022
Q1 		$11.8M Buy
622,293
+413,469
+198% +$8.04M 0.01% 1959
2021
Q4 		$3.89M Buy
208,824
+156,249
+297% +$3.22M ﹤0.01% 3152
2021
Q3 		$1.41M Buy
52,575
+42,788
+437% +$1.18M ﹤0.01% 4300
2021
Q2 		$306K Buy
+9,787
New +$312K ﹤0.01% 5708

Other funds holding TMCI

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
GA
Gagnon Advisors New York $157M AUM 36.77% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
CBU
CIBC Bancorp USA Chicago, Illinois $82.3B AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Israel Englander's TMCI Position: Q2 2026 in Review

Israel Englander reduced its Treace Medical Concepts (TMCI) stake by 36% in Q2 2026, selling an estimated $1.13M and leaving 738,628 shares worth $2.94M. The position accounts for ﹤0.01% of the portfolio, ranked #3498.

Israel Englander first reported a position in TMCI in Q2 2021 and has held it in 19 quarters since. The position peaked at $26.6M in Q1 2024. 117 funds tracked by Wall St. Rank hold TMCI as of Q2 2026.

  • Israel Englander held 738,628 shares of Treace Medical Concepts worth $2.94M as of Q2 2026.
  • Israel Englander sold 409,487 Treace Medical Concepts shares in Q2 2026, an estimated $1.13M.
  • Treace Medical Concepts made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #3498 holding.
  • Israel Englander first reported a position in Treace Medical Concepts in Q2 2021 and has held it in 19 quarters since.
  • Israel Englander's Treace Medical Concepts position peaked at $26.6M in Q1 2024.
  • 117 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.